The weekly litigation news digest is live. Subscribe now

IP Verse

Neurocrine Biosciences competitive analysis

Loading summary...

Latest oppositions filed by Neurocrine Biosciences

Explore patent oppositions filed by Neurocrine Biosciences against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3784233
Methods For Treating Testicular And Ovarian Adrenal Rest TumorsSPRUCE BIOSCIENCESDec 10, 2024

Latest patents of Neurocrine Biosciences opposed by its competitors

Explore Neurocrine Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3096756
Jun 12, 2024Crf1 Receptor Antagonists For The Treatment Of Congenital Adrenal Hyperplasia1

Latest PTAB cases involving Neurocrine Biosciences

Discover the latest PTAB cases involving Neurocrine Biosciences, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 19, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Neurocrine Biosciences

PGR2025-00032Feb 10, 2025NEUROCRINE BIOSCIENCESSPRUCE BIOSCIENCESInstitution Denied
PGR2022-00025Feb 18, 2022NEUROCRINE BIOSCIENCESSPRUCE BIOSCIENCESFinal Written Decision
PGR2021-00088May 28, 2021NEUROCRINE BIOSCIENCESSPRUCE BIOSCIENCESFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Neurocrine Biosciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NEUROCRINE BIOSCIENCES113 -
KRAUS & LEDERER PARTGMBB68 - - -
SPRUCE BIOSCIENCES - 1 - 3